An interventional study of Cough Assist® (JH Emerson Compagny, Cambridge, MA, USA) in Neuromuscular Disease, sponsored by Centre d'Investigation Clinique et Technologique 805. Completed at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2018-01-25.
Sponsored by Centre d'Investigation Clinique et Technologique 805 · Not applicable, Interventional, and Treatment
The investigators want to demonstrate that there is an optimal expiratory pressure when using mecanical in-exsufflation for each patient in neuromuscular disease. This compromise is between the need to generate a high pressure difference between alveoli and the mouth and the need to avoide and superior airways collapsus.
he investigators want to demonstrate that there is an optimal expiratory pressure when using mecanical in-exsufflation for each patient in neuromuscular disease. This compromise is between the need to generate a high pressure difference between alveoli and the mouth and the need to avoide and superior airways collapsus.
300 studies on the registry are indexed under Neuromuscular Diseases; 87 are open to participants now.
This study's enrollment of 40 is above the median of 32 across 168 interventional studies indexed under Neuromuscular Diseases.
Browse Neuromuscular Diseases studies →Centre d'Investigation Clinique et Technologique 805 is the lead sponsor of 74 studies on the registry; 2 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
Cough Assist® (JH Emerson Compagny, Cambridge, MA, USA)
Device: Cough Assist® (JH Emerson Compagny, Cambridge, MA, USA)
Cough Assist® (JH Emerson Compagny, Cambridge, MA, USA) mechanical insufflation to increase peak cough flow
optimal negative pressure treshold value
Optimal negative pressure treshold value measured for a flow superior or equal to 160 liter/minute and 270 liter/minute
Time frame: 20 minutes
optimal pressure treshold based on the best peak flow.
Time frame: 10 minutes
volume-flow curve aspect
Time frame: 5 minutes
This study is completed, as verified in Nov 2017. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Centre d'Investigation Clinique et Technologique 805